 |
|
Secular Trends in Cardiovascular Disease Risk Factors According to Body Mass Index in US Adults
Edward W. Gregg, PhD;
Yiling J. Cheng, MD, PhD;
Betsy L. Cadwell, MSPH;
Giuseppina Imperatore, MD, PhD;
Desmond E. Williams, MD, PhD;
Katherine M. Flegal, PhD;
K. M. Venkat Narayan, MD;
David F. Williamson, PhD
JAMA. 2005;293:1868-1874.
ABSTRACT
| |
Context Prevalence of obesity in the United States has increased dramatically in recent decades, but the magnitude of change in cardiovascular disease (CVD) risk factors among the growing proportion of overweight and obese Americans remains unknown.
Objective To examine 40-year trends in CVD risk factors by body mass index (BMI) groups among US adults aged 20 to 74 years.
Design, Setting, and Participants Analysis of 5 cross-sectional, nationally representative surveys: National Health Examination Survey (1960-1962); National Health and Nutrition Examination Survey (NHANES) I (1971-1975), II (1976-1980), and III (1988-1994); and NHANES 1999-2000.
Main Outcome Measures Prevalence of high cholesterol level ( 240 mg/dL [6.2 mmol/L] regardless of treatment), high blood pressure (140/90 mm Hg regardless of treatment), current smoking, and total diabetes (diagnosed and undiagnosed combined) according to BMI group (lean, <25; overweight, 25-29; and obese, 30).
Results The prevalence of all risk factors except diabetes decreased over time across all BMI groups, with the greatest reductions observed among overweight and obese groups. Compared with obese persons in 1960-1962, obese persons in 1999-2000 had a 21-percentage-point lower prevalence of high cholesterol level (39% in 1960-1962 vs 18% in 1999-2000), an 18-percentage-point lower prevalence of high blood pressure (from 42% to 24%), and a 12-percentage-point lower smoking prevalence (from 32% to 20%). Survey x BMI group interaction terms indicated that compared with the first survey, the prevalence of high cholesterol in the fifth survey had fallen more in obese and overweight persons than in lean persons (P<.05). Survey x BMI changes in blood pressure and smoking were not statistically significant. Changes in risk factors were accompanied by increases in lipid-lowering and antihypertensive medication use, particularly among obese persons. Total diabetes prevalence was stable within BMI groups over time, as nonsignificant 1- to 2-percentage-point increases occurred between 1976-1980 and 1999-2000.
Conclusions Except for diabetes, CVD risk factors have declined considerably over the past 40 years in all BMI groups. Although obese persons still have higher risk factor levels than lean persons, the levels of these risk factors are much lower than in previous decades.
INTRODUCTION
There has been a marked increase in overweight and obesity in the United States over the past 25 years, with the prevalence of obesity among adults aged 20 to 74 years rising from 13% to 31%.1-3 This increase in prevalence of obesity has occurred among both men and women and across all racial/ethnic and age groups. Prospective cohort studies as well as national surveys have shown that obese individuals have an increased risk of several adverse health outcomes, notably hypertension, diabetes, cardiovascular disease (CVD), arthritis, disability, and mortality.4-8 Accordingly, numerous clinical consensus panels and public health organizations have recommended that persons with a body mass index (BMI) of 30 or higher, or with risk factors and a BMI of 25 or higher, achieve and maintain a lower weight.9-10
Despite the scope and magnitude of the observed increases in obesity, the health implications of these trends for the US population remain unclear. Although increases in obesity have been accompanied by increases in diabetes,11-13 the association between obesity trends and other CVD risk factors remains less certain. In the overall population, mortality rates from ischemic heart disease as well as levels of key CVD risk factors have declined during the past 30 years,14-19 but whether comparable improvements have occurred across levels of BMI remains unknown.
Using data from the 5 consecutive nationally representative health surveys conducted during the last 40 years, we examined whether long-term secular changes in levels of key cardiovascular risk factors have been different in overweight or obese persons compared with lean persons. We examined changes in current smoking status, diagnosed and undiagnosed diabetes, and high blood pressure and high total cholesterol levels. For blood pressure and cholesterol, we analyzed actual values, regardless of treatment, so that levels could be influenced by trends in medical care as well as by environmental and behavioral changes that may have occurred.
METHODS
Overall Design and Study Population
The National Health Examination Survey (NHES) and the National Health and Nutrition Examination Surveys (NHANES) are a series of cross-sectional health examination surveys representative of the United States civilian noninstitutionalized population. They were conducted in 1960-1962 (NHES), 1971-1975 (NHANES I), 1976-1980 (NHANES II), 1988-1994 (NHANES III), and 1999-2000 (NHANES 1999-2000). Each of the surveys followed a stratified multistage probability design in which a sample of the US population is selected. Detailed descriptions of the plan and operation of each survey have been published.20-24 To maximize comparability across the 5 surveys, we restricted analyses to examined, nonpregnant adults who were aged 20 to 74 years. This consisted of 6257, 12 911, 11 765, 14 319, and 3601 persons in the 5 surveys, respectively.
NHANES III and NHANES 1999-2002 have undergone institutional review board approval and included written informed consent. Institutional review board approval using current standards was not obtained for NHES, NHANES I, or NHANES II, but internal human subjects review was conducted.
Measurements
Each survey included a standardized examination to obtain information on height, weight, and CVD risk factors. Weight and height were measured by a standard protocol and used to calculate BMI; ie, weight in kilograms divided by the square of height in meters. We refer to BMI groups of <25, 25 to 29.9, and 30 as "lean," "overweight," and "obese," respectively. Four CVD risk factors were analyzed: serum total cholesterol concentration, blood pressure, smoking status, and diabetes. These risk factors were chosen because they were assessed in at least 4 surveys, using similar methods across all surveys.
Cholesterol analyses were conducted on venous blood serum samples and standardized according to previously published methods.16, 25-26 The samples were frozen at –20°C and shipped weekly on dry ice to the laboratory conducting the lipid analyses. The NHES and NHANES I measurements were made in the Centers for Disease Control and Prevention Lipid Standardization Laboratory. The NHANES II, III, and 1999-2000 measurements were made in lipid research clinic laboratories that were standardized for cholesterol measurements according to the criteria of the CDC–National Heart, Lung, and Blood Institute Lipid Standardization Program.
Blood pressure was measured according to standard protocols that differed somewhat across the 5 surveys.15 For consistency, we used only blood pressure measurements conducted in the mobile examination center with participants in a seated position. Because large adult and thigh blood pressure cuffs were available only for the latter 2 surveys, blood pressure could be overestimated among obese persons in early surveys. Thus, we computed an adjusted blood pressure according to methods suggested by Maxwell et al27 to account for arm circumference and cuff size.28
Previously diagnosed diabetes was determined by asking participants whether a physician or other health care professional had ever told the respondent that he or she had diabetes. For the latter 3 surveys, undiagnosed diabetes was assessed among subsamples (n = 3786, n = 5791, and n = 1434 in NHANES II, III, and 1999-2000, respectively) of nondiabetic persons randomly assigned to a morning fasting examination session.29-32 Procedures for blood collection and processing have been described.23-24,29, 31-32 We used American Diabetes Association diagnostic criteria for undiagnosed diabetes (fasting glucose level 126 mg/dL [6.99 mmol/L]). Total diabetes prevalence was calculated as the sum of the diagnosed diabetes from the interview sample and undiagnosed diabetes from the fasting morning sample, adjusted using methods previously described.30
To determine current cigarette smoking, respondents were asked, "Have you smoked at least 100 cigarettes in your entire life?" and "Do you smoke cigarettes now?" Current smoking was defined as a positive answer to both questions. Smoking was not assessed in the NHES and, thus, is reported only for the latter 4 surveys. For NHANES I, only a subsample of persons aged 25 to 74 years were asked about smoking. Thus, for smoking, we restricted our analyses to persons aged 25 to 74 years for the remaining surveys (n = 3823, n = 10 389, n = 12641, and n = 3271 among NHANES I, II, III, and 1999-2000, respectively).
Definitions of Primary Outcomes
We defined high blood pressure as systolic blood pressure of at least 140 mm Hg or diastolic blood pressure of at least 90 mm Hg28 using the cuff-size–corrected measurements. We defined high total cholesterol level as at least 240 mg/dL (6.20 mmol/L).33 High blood pressure and high cholesterol level were defined according to levels of control regardless of use of medications. These definitions better capture the impact of secular clinical and public health factors and are less vulnerable to recall bias than definitions based on treatment status. Although current standards recommend lower levels of total cholesterol and blood pressure, these cut points represent common definitions of risk factors across the period of our study (1960-2000). Smoking was defined as smoking status at the time of the survey. Total diabetes was defined as either previously diagnosed diabetes (by self-report) or, for those without previously diagnosed diabetes, a fasting glucose level of at least 126 mg/dL (6.99 mmol/L). Since fasting glucose measurements were available only for the latter 3 surveys, we conducted additional analyses of diagnosed diabetes across all 5 surveys.
Participants were asked about whether they had been told by a physician to take prescribed medicine to lower blood cholesterol level and whether they were currently taking medication for high blood pressure. These were used to define the prevalence of medication use, with the entire population used as the denominator. We also used this information to perform additional analyses in which we defined the outcome as having a high level or taking medication treatment for the condition. For the latter analysis, prevalence of lipid-lowering medication use during the first 3 surveys (1960-1980) was assumed to be zero.
Statistical Analysis
For all surveys, sampling weights had been calculated that take into account unequal probabilities of selection resulting from the sample design, nonresponse, and planned oversampling of certain subgroups. Data management was conducted using SAS software, version 9.1.34 Standard errors were calculated with SUDAAN software, version 9.0, to account for the complex sample and to apply survey weights to make results representative of the civilian, noninstitutionalized US population.35 For estimates of total diabetes, we computed standard errors using a jackknife variance estimator because the summation of diagnosed and undiagnosed diabetes violated assumptions of statistical independence.36 For high cholesterol, high blood pressure, smoking, and diagnosed diabetes, we used multiple logistic regression and computed predictive marginals to estimate the prevalence of each CVD risk factor by survey and BMI group when controlling for age and sex.36 Predictive marginals are a type of direct standardization in which the predicted values from the logistic regression models are averaged over the covariate distribution of the population. Using the predictive marginals and standard errors, we present differences and 95% confidence intervals (CIs) in prevalence of risk factors over time according to BMI group. Significance of interaction terms between BMI groups and survey years from the logistic models were assessed to determine if changes throughout the 40-year period and between the first and last surveys differed by BMI group.
RESULTS
Table 1 lists the characteristics of the participants across the 5 NHANES surveys, weighted to the US population. In addition to the previously reported increases in body weight and BMI,1-2 substantial increases in educational level occurred across the period covered by the surveys. Within BMI strata, there were generally only minor increases in mean BMI across surveys. Within the obese category, however, mean BMI increased from 33.6 in 1960-1962 to 35.8 in 1999-2000.
|
|
|
|
Table 1. Survey Sample Characteristics*
|
|
|
As has been previously documented,15-16,19 there were large reductions (33% to 52% relative to baseline) in the prevalence of high cholesterol level, high blood pressure, and smoking in the overall population during the past 30 to 40 years (Table 2). However, the prevalence of obesity and diagnosed diabetes doubled during this period, and between 1976-1980 and 1999-2000, the prevalence of total (diagnosed and undiagnosed) diabetes increased by 55%.1-2,29, 32
|
|
|
|
Table 2. Age- and Sex-Adjusted Trends in Cardiovascular Risk Factors in the US Population Aged 20 to 74 Years*
|
|
|
CVD Disease Risk Factors by BMI
Between 1960-1962 and 1999-2000, the age- and sex-adjusted prevalence of high cholesterol, high blood pressure, and smoking levels decreased among all BMI groups (Table 2). The prevalence of total diabetes remained stable within BMI groups across decades, while the prevalence of diagnosed diabetes increased among overweight and obese groups.
Absolute reductions in the prevalence of high cholesterol between 1960 and 2000 were greater for overweight (21-percentage-point decline; 95% CI, 17%-25%) and obese persons (21-percentage-point decline; 95% CI, 15%-27%) than for those of lean persons (12-percentage-point decline; 95% CI, 8%-16%). Obese persons had a 9- to 12-percentage-point higher prevalence of high cholesterol level than lean persons across all surveys, but by 1999-2000, this difference was only 2.7 percentage points. The overall test for the 8 survey x BMI interaction terms was not statistically significant. However, the interaction terms comparing change in prevalence of high cholesterol level between the first and fifth surveys showed a statistically significantly greater reduction in prevalence of high cholesterol level among obese (P = .02) and overweight (P<.05) persons compared with lean persons.
Prevalence of high blood pressure also tended to decline more over time among obese (18 percentage points; 95% CI, 13%-23%) and overweight (17 percentage points; 95% CI, 13%-21%) persons than among lean persons (14 percentage points; 95% CI, 11%-18%). However, the prevalence of high blood pressure among obese persons remained at least twice that of lean persons (24% vs 11%) in 1999-2000. Moreover, survey x BMI group interaction terms comparing the first and fifth surveys were not statistically significant for obese (P = .25) and overweight (P = .76) persons compared with lean persons, indicating that secular declines in high blood pressure did not differ by BMI.
The prevalence of smoking was lowest among obese persons and highest among lean persons across all 5 surveys (Table 2). This prevalence declined among all BMI groups by a similar magnitude (12- to 13-percentage-point change across groups) such that about one third of lean persons and one fifth of obese persons reported smoking in 1999-2000. Survey x BMI interaction terms were not significant for smoking.
Prevalence of total diabetes (diagnosed and undiagnosed combined) was stable over time within BMI groups, increasing by only 1 to 2 percentage points between 1976-1980 and 1999-2000. In contrast, prevalence of diagnosed diabetes was about 2.5 to 3.5 times as high in 2000 as in 1960 among overweight (from 1.6% to 4.2%) and obese (from 2.9% to 10.1%) persons (Table 2). The survey x BMI group interaction comparing diagnosed diabetes prevalence in the first vs fifth surveys was statistically significant for obese persons (P = .03) but not overweight persons (P = .28), indicating that secular increases in prevalence of diagnosed diabetes were greater among obese than lean persons.
Trends in Antihypertensive and Lipid-Lowering Medications
The proportion of the overall population receiving medication treatment for high cholesterol level and high blood pressure increased among all BMI groups (Table 3). The prevalence of treatment for high cholesterol increased more among obese persons (from 3.5% to 9.2%) than among lean persons (from 2.2% to 4%), although the survey x BMI group interaction terms were not significant. The prevalence of treatment for high blood pressure increased significantly more among obese persons (from 11% to 28%) and overweight persons (from 6% to 17%) than among lean persons (from 5% to 8%) (P<.01 for interaction terms).
|
|
|
|
Table 3. Age- and Sex-Adjusted Prevalence of US Adults Aged 20 to 74 Years Reporting Cholesterol and Blood Pressure Medication Use*
|
|
|
When we examined prevalence estimates using a definition of risk as having either high levels or receiving treatment, there were still reductions in prevalence over time (Table 4). However, the magnitude of reduction in prevalence over time was less than observed in our primary analyses when risk levels were defined irrespective of treatment (Table 2). For example, the magnitude of reductions in prevalence of having high cholesterol levels or taking medication ranged from 9 to 13 percentage points across the 3 BMI groups. The magnitude of reductions in prevalence of having high blood pressure levels or receiving medication ranged from 4 to 10 percentage points across the 3 BMI groups, with the smallest reduction noted in the obese group (P<.01 for interaction term).
|
|
|
|
Table 4. Age- and Sex-Adjusted Prevalence of High Levels of or Current Treatment for Cholesterol and Blood Pressure Among US Adults Aged 20 to 74 Years*
|
|
|
COMMENT
In this unique series of nationally representative surveys of the US adult population, we documented a substantial decline in the prevalence of key CVD risk factors over the last 3 to 4 decades, affecting obese, overweight, and lean segments of the population. Among obese persons today, prevalence of high cholesterol, high blood pressure, and smoking are now 21, 18, and 12 percentage points lower, respectively, than among obese persons 30 to 40 years ago. The corresponding reductions among lean persons have been somewhat less, with average declines of 12 to 14 percentage points. Although obesity remains associated with a higher prevalence of important CVD risk factors, differences in total cholesterol levels across BMI groups may be narrowing, and for blood pressure and smoking improvements have been similar across BMI groups. Thus, obese and overweight persons may be at lower risk of CVD now than in previous eras.
Diabetes is a notable exception to the observed reduction in risk factors, as prevalence of total diabetes (ie, diagnosed and undiagnosed combined) did not decrease within BMI groups. This was accompanied by a 55% increase in total diabetes among the overall population (ie, all BMI groups combined), presumably due to an increasing proportion of the population moving into the obese categories. Diagnosed diabetes alone, on the other hand, increased more among obese persons than other groups, but presumably due to greater increases in detection among obese than lean persons. In a detailed examination of diabetes trends,13 we recently found that undiagnosed diabetes decreased considerably among the most obese persons (particularly those with BMI >35), and the proportion of total cases that were diagnosed increased dramatically. These observations, combined with our findings of increased cholesterol-lowering and antihypertensive medication use, also suggest that the health care system is placing greater emphasis on preventive care among obese persons.
The observation that obese persons now have better CVD risk factor profiles than their leaner counterparts did 20 to 30 years ago, combined with trend data in the general population, suggests that other factors may be compensating for the increases in obesity.15, 17-18,37-43 Studies have documented a mixture of both deleterious and beneficial trends in the US population. Trends promoting obesity include increases in total calories, portion sizes, refined carbohydrates, and fast food intake.18, 39-41,44-45 Healthy trends include decreases in the proportion of dietary saturated fat; increases in fruits, vegetables, and the proportion of polyunsaturated and monounsaturated fats in the diet17-18,39-43; and decreased smoking, which, ironically, may have contributed somewhat to increasing obesity.43 Although trends in overall physical activity levels remain unclear, recent estimates suggest walking prevalence may have increased, particularly among obese persons.46 All of these changes appear to be overlaid on a background of increased awareness, aggressive identification, and pharmacological treatment of high cholesterol and blood pressure levels.15, 37-38 Increased awareness about obesity and its association with CVD may have further fueled the changes observed among overweight and obese persons. The net result of these phenomena may be a population that is, paradoxically, more obese, diabetic, arthritic, disabled, and medicated, but with lower overall CVD risk.2, 4-7,47
Although our study does not directly address the causes of changes in risk factors, our results are consistent with both pharmacological and nonpharmacological factors playing a causal role. Two observations support a role for pharmacological factors: First, we found that the prevalence of lipid-lowering and antihypertensive medication increased in all groups, particularly among obese persons. Second, when we defined our outcomes as either high levels or receipt of treatment, we found that the magnitude of reduction was less than in our primary analyses, where risk was defined irrespective of treatment. However, we interpret these latter findings with caution because changes in clinical definitions and treatment guidelines over time make people more likely to be treated at lower levels of risk in later surveys. This could have the effect of overestimating prevalence in later surveys when we define risk as either high levels or receipt of treatment. Furthermore, our observation that risk factors were lower over time regardless of whether treatment was part of the definition suggests that nonpharmacological factors influenced these trends as well.
Our findings are supported by other ecologic observations, including reductions in CVD and ischemic heart disease mortality in the general population,14, 19 as well as simultaneous BMI increases and CVD risk factor reductions in the Minnesota Heart Survey.18 A report from the WHO-MONICA study48 that examined the correlation between changes in risk factors and coronary heart disease (CHD) incidence rates from 38 separate international populations found that increasing BMI trends were actually associated with declining CHD rates among men; among women, there was no association between changes in BMI and CHD. These findings from the WHO-MONICA study suggest that changes in obesity are a relatively minor determinant of CHD trends and remind us that BMI is only one among many determinants of CVD risk.
Our analyses have several limitations. First, we did not examine BMI-specific trends in dietary intake, physical activity levels, lipid subfractions, body fat distribution, inflammation markers, musculoskeletal disorders, or health-related quality of life. Second, the lack of extra-large blood pressure cuffs in early surveys could exaggerate earlier blood pressure levels as well as declines in blood pressure among obese persons over time. However, we corrected all blood pressure values for cuff size and arm circumference. Third, the sample size for NHANES 1999-2000 was considerably smaller than the earlier surveys. Inferences about changes between the latter 2 surveys should thus be drawn with caution. Fourth, our analyses did not adjust for shifts in race/ethnicity over survey years because of changes in the way race/ethnicity was assessed. However, when we adjusted for nonwhite race, we found essentially no difference in our findings. Finally, we examined some risk factors irrespective of treatment. This assumes, not quite correctly, that a person is considered not at risk despite receiving treatment as long as their risk factor levels are controlled. We selected this approach because we were interested in capturing the full range of secular trends that may have occurred, whether from medical care, behavioral, or environmental sources. Note, however, that for diabetes we had no comparable measure for risk subsequent to treatment because levels of glycemia were not assessed among persons with diabetes. Thus, there may have been some level of CVD risk reduction associated with improving glycemic control and better treatment that we could not measure.
In summary, our study found that with the exception of diabetes, CVD risk factor levels have declined over recent decades among all BMI groups. While obesity remains associated with elevated levels of several CVD risk factors compared with lean persons, their levels of risk factors have now diminished such that they are lower than those of lean individuals 20 to 30 years ago. In addition to determining the key reasons for the favorable trends we observed, future studies should examine whether these changes extend to incidence of morbidity, including cardiovascular disease incidence and disability. Despite our encouraging findings, a considerable proportion of lean as well as obese persons still have elevated levels of modifiable risk factors, particularly when one considers that the current definitions of risk factor control are more aggressive than the definitions used in this trend analyses. Clinical and public health efforts should continue to emphasize maintenance of healthy lifestyle behaviors for lean as well as overweight and obese persons.
AUTHOR INFORMATION
Corresponding Author: Edward W. Gregg, PhD, Division of Diabetes Translation, Centers for Disease Control and Prevention, 4770 Buford Hwy NE, Mailstop K-10, Atlanta, GA 30341 (edg7{at}cdc.gov).
Author Contributions: Dr Gregg had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
Study concept and design: Gregg, Cheng, Imperatore, Williams, Narayan, Williamson.
Acquisition of data: Imperatore.
Analysis and interpretation of data: Gregg, Cheng, Cadwell, Imperatore, Williams, Flegal, Williamson.
Drafting of the manuscript: Gregg, Cheng, Flegal.
Critical revision of the manuscript for important intellectual content: Gregg, Cheng, Cadwell, Imperatore, Williams, Flegal, Narayan, Williamson.
Statistical analysis: Gregg, Cheng, Cadwell, Imperatore, Williams, Flegal, Williamson.
Administrative, technical, or material support: Gregg.
Study supervision: Narayan.
Financial Disclosures: None reported.
Author Affiliations: Division of Diabetes Translation, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Ga (Drs Gregg, Cheng, Imperatore, Williams, Narayan, and Williamson and Ms Cadwell); National Center for Health Statistics, Centers for Disease Control and Prevention, Hyattsville, Md (Dr Flegal).
REFERENCES
| |
1. Flegal KM, Carroll MD, Kuczmarski RJ, Johnson CL. Overweight and obesity in the United States: prevalence and trends, 1960-1994. Int J Obes Relat Metab Disord. 1998;22:39-47.
FULL TEXT
|
ISI
| PUBMED
2. Flegal KM, Carroll MD, Ogden CL, Johnson CL. Prevalence and trends in obesity among US adults, 1999-2000. JAMA. 2002;288:1723-1727.
FREE FULL TEXT
3. Mokdad AH, Serdula MK, Dietz WH, et al. The spread of the obesity epidemic in the United States, 1991-1998. JAMA. 1999;282:1519-1522.
FREE FULL TEXT
4. Rissanen A, Heliovaara M, Knekt P, et al. Risk of disability and mortality due to overweight in a Finnish population. BMJ. 1990;301:835-837.
FREE FULL TEXT
5. Launer LJ, Harris T, Rumpel C, Madans J. Body mass index, weight change, and risk of mobility disability in middle-aged and older women. JAMA. 1994;271:1093-1098.
FREE FULL TEXT
6. Brown CD, Higgins M, Donato KA, et al. Body mass index and the prevalence of hypertension and dyslipidemia. Obes Res. 2000;8:605-619.
ISI
| PUBMED
7. Visscher TL, Rissanen A, Seidell JC, et al. Obesity and unhealthy life-years in adult Finns: an empirical approach. Arch Intern Med. 2004;164:1413-1420.
FREE FULL TEXT
8. Wilson PW, D’Agostino RB, Sullivan L, Parise H, Kannel WB. Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Arch Intern Med. 2002;162:1867-1872.
FREE FULL TEXT
9. National Institutes of Health. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults—the evidence report. Obes Res. 1998;6(suppl 2):51S-209S.
ISI
| PUBMED
10. Willett WC, Dietz WH, Colditz GA. Guidelines for healthy weight. N Engl J Med. 1999;341:427-434.
FREE FULL TEXT
11. Centers for Disease Control and Prevention Prevalence of diagnosed diabetes by age, United States, 1980-2000. Available at: http://www.cdc.gov/diabetes/statistics/prev/national/figbyage.htm. Accessed December 16, 2003.
12. Fagot-Campagna A, Pettitt DJ, Engelgau MM, et al. Type 2 diabetes among North American children and adolescents. J Pediatr. 2000;136:664-672.
FULL TEXT
|
ISI
| PUBMED
13. Gregg EW, Cadwell BL, Cheng YJ, et al. Trends in the prevalence and ratio of diagnosed to undiagnosed diabetes according to obesity levels in the US. Diabetes Care. 2004;27:2806-2812.
FREE FULL TEXT
14. Rosamond WD, Chambless LE, Folsom AR, et al. Trends in the incidence of myocardial infarction and in mortality due to coronary heart disease, 1987 to 1994. N Engl J Med. 1998;339:861-867.
FREE FULL TEXT
15. Burt VL, Cutler JA, Higgins M, et al. Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population. Hypertension. 1995;26:60-69.
FREE FULL TEXT
16. Johnson CL, Rifkind BM, Sempos CT, et al. Declining serum total cholesterol levels among US adults. JAMA. 1993;269:3002-3008.
FREE FULL TEXT
17. Achievements in public health: tobacco use—United States, 1900-1999. MMWR Morb Mortal Wkly Rep. 1999;48:986-993.
PUBMED
18. Arnett DK, McGovern PG, Jacobs DR Jr, et al. Fifteen-year trends in cardiovascular risk factors (1980-1982 through 1995-1997): the Minnesota Heart Survey. Am J Epidemiol. 2002;156:929-935.
FREE FULL TEXT
19. Cooper R, Cutler J, Desvigne-Nickens P, et al. Trends and disparities in coronary heart disease, stroke, and other cardiovascular diseases in the United States. Circulation. 2000;102:3137-3147.
FREE FULL TEXT
20. McDowell A, Engel A, Massey JT, Maurer K. Plan and operation of the second Health and Nutrition Examination Survey, United States 1976-80. Vital Health Stat 1. 198115:1-144.
PUBMED
21. Plan and operation of the initial program of the Health Examination Survey. Vital Health Stat 1. 1965;4:1-43.
PUBMED
22. Miller HW. Plan and operation of the Health and Nutrition Examination Survey, United States 1971-1973. Vital Health Stat 1. 1973;110a:1-46.
PUBMED
23. Plan and operation of the Third National Health and Nutrition Examination Survey, 1988-1994: series 1: programs and collection procedures. Vital Health Stat 1. 1994(32):1-407.
PUBMED
24. National Center for Health Statistics NHANES 1999-2000 data files: data, docs, codebooks, SAS code. Available at: http://www.cdc.gov/nchs/about/major/nhanes/NHANES99_00.htm. Accessed April 22, 2003.
25. Lipid Research Clinics Program. Manual of Laboratory Operations, Volume 1: Lipid and Lipoprotein Analysis. Rev ed. Bethesda, Md: National Institutes of Health; 1982.
26. Myers GL, Cooper GR, Winn CL, Smith SJ. The Centers for Disease Control–National Heart, Lung and Blood Institute Lipid Standardization Program: an approach to accurate and precise lipid measurements. Clin Lab Med. 1989;9:105-135.
ISI
| PUBMED
27. Maxwell MH, Waks AU, Schroth PC, Karam M, Dornfeld LP. Error in blood-pressure measurement due to incorrect cuff size in obese patients. Lancet. 1982;2:33-36.
FULL TEXT
|
ISI
| PUBMED
28. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med. 1997;157:2413-2446.
FREE FULL TEXT
29. Prevalence of diabetes and impaired fasting glucose in adults—United States, 1999-2000. MMWR Morb Mortal Wkly Rep. 2003;52:833-837.
PUBMED
30. Flegal KM, Ezzati TM, Harris MI, et al. Prevalence of diabetes in Mexican Americans, Cubans, and Puerto Ricans from the Hispanic Health and Nutrition Examination Survey, 1982-1984. Diabetes Care. 1991;14:628-638.
ABSTRACT
31. Harris MI, Hadden WC, Knowler WC, Bennett PH. Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in US population aged 20-74 yr. Diabetes. 1987;36:523-534.
ABSTRACT
32. Harris MI, Flegal KM, Cowie CC, et al. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in US adults. Diabetes Care. 1998;21:518-524.
ABSTRACT
33. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106:3143-3421.
FREE FULL TEXT
34. SAS Procedures Guide. Cary, NC: SAS Institute Inc; 1999.
35. SUDAAN User’s Manual. Research Triangle Park, NC: Research Triangle Institute; 2003.
36. Korn EL, Graubard BI Analysis of Health Surveys. New York, NY: Wiley; 1999.
37. Kumanyika SK, Landis JR, Matthews-Cook YL, Almy SL, Boehmer SJ. Systolic blood pressure trends in US adults between 1960 and 1980. Am J Epidemiol. 1998;148:528-538.
FREE FULL TEXT
38. Siegel D, Lopez J, Meier J. Use of cholesterol-lowering medications in the United States from 1991 to 1997. Am J Med. 2000;108:496-499.
FULL TEXT
|
ISI
| PUBMED
39. Briefel RR, Johnson CL. Secular trends in dietary intake in the United States. Annu Rev Nutr. 2004;24:401-431.
FULL TEXT
|
ISI
| PUBMED
40. Centers for Disease Control and Prevention. Trends in intake of energy and macronutrients—United States, 1971-2000. MMWR Morb Mortal Wkly Rep. 2004;53:80-82.
PUBMED
41. Ernst ND, Sempos CT, Briefel RR, Clark MB. Consistency between US dietary fat intake and serum total cholesterol concentrations. Am J Clin Nutr. 1997;66(4 suppl):965S-972S.
FREE FULL TEXT
42. Li R, Serdula M, Bland S, Mokdad A, Bowman B, Nelson D. Trends in fruit and vegetable consumption among adults in 16 US states. Am J Public Health. 2000;90:777-781.
FREE FULL TEXT
43. Flegal KM, Troiano RP, Pamuk ER, Kuczmarski RJ, Campbell SM. The influence of smoking cessation on the prevalence of overweight in the United States. N Engl J Med. 1995;333:1165-1170.
FREE FULL TEXT
44. Gross LS, Li L, Ford ES, Liu S. Increased consumption of refined carbohydrates and the epidemic of type 2 diabetes in the United States: an ecologic assessment. Am J Clin Nutr. 2004;79:774-779.
FREE FULL TEXT
45. Nielsen SJ, Popkin BM. Patterns and trends in food portion sizes, 1977-1998. JAMA. 2003;289:450-453.
FREE FULL TEXT
46. Simpson ME, Serdula M, Galuska DA, et al. Walking trends among US adults. Am J Prev Med. 2003;25:95-100.
FULL TEXT
|
ISI
| PUBMED
47. Sturm R, Ringel JS, Andreyeva T. Increasing obesity rates and disability trends. Health Aff (Millwood). 2004;23:199-205.
FREE FULL TEXT
48. Kuulasmaa K, Tunstall-Pedoe H, Dobson A, et al. Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project populations. Lancet. 2000;355:675-687.
FULL TEXT
|
ISI
| PUBMED
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
RELATED ARTICLES
Excess Deaths Associated With Underweight, Overweight, and Obesity
Katherine M. Flegal, Barry I. Graubard, David F. Williamson, and Mitchell H. Gail
JAMA. 2005;293(15):1861-1867.
ABSTRACT
| FULL TEXT
Deaths Attributable to Obesity
David H. Mark
JAMA. 2005;293(15):1918-1919.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Normal weight obesity: a risk factor for cardiometabolic dysregulation and cardiovascular mortality
Romero-Corral et al.
Eur Heart J 2009;0:ehp487v1-ehp487.
ABSTRACT
| FULL TEXT
Sibutramine for weight gain attenuation during smoking cessation with varenicline: A pilot study
Sood et al.
Nicotine Tob Res 2009;0:ntp162v2-ntp162.
ABSTRACT
| FULL TEXT
Hypertension, Diabetes, And Elevated Cholesterol Among Insured And Uninsured U.S. Adults
Wilper et al.
Health Aff (Millwood) 2009;28:w1151-w1159.
ABSTRACT
| FULL TEXT
A Prospective Study of Bone Lead Concentration and Death From All Causes, Cardiovascular Diseases, and Cancer in the Department of Veterans Affairs Normative Aging Study
Weisskopf et al.
Circulation 2009;120:1056-1064.
ABSTRACT
| FULL TEXT
A 52-Year-Old Woman With Obesity: Review of Bariatric Surgery
Wee
JAMA 2009;302:1097-1104.
ABSTRACT
| FULL TEXT
Declining cardiovascular mortality and increasing obesity: a paradox
Rosengren
CMAJ 2009;181:127-128.
FULL TEXT
Does Greater Adiposity Increase Blood Pressure and Hypertension Risk?: Mendelian Randomization Using the FTO/MC4R Genotype
Timpson et al.
Hypertension 2009;54:84-90.
ABSTRACT
| FULL TEXT
Exercise Training for Type 2 Diabetes Mellitus: Impact on Cardiovascular Risk: A Scientific Statement From the American Heart Association
Marwick et al.
Circulation 2009;119:3244-3262.
FULL TEXT
Prevalence and Incidence of Endocrine and Metabolic Disorders in the United States: A Comprehensive Review
Golden et al.
J. Clin. Endocrinol. Metab. 2009;94:1853-1878.
ABSTRACT
| FULL TEXT
Health and Functioning Among Baby Boomers Approaching 60
Martin et al.
J Gerontol B Psychol Sci Soc Sci 2009;64B:369-377.
ABSTRACT
| FULL TEXT
American Heart Association Childhood Obesity Research Summit Report
Daniels et al.
Circulation 2009;119:e489-e517.
FULL TEXT
Long-Term Trends in Myocardial Infarction Incidence and Case Fatality in the National Heart, Lung, and Blood Institute's Framingham Heart Study
Parikh et al.
Circulation 2009;119:1203-1210.
ABSTRACT
| FULL TEXT
Upward Hypertension Trends: Changes in Blood Pressure or in Antihypertensive Treatment?
Chiolero et al.
Hypertension 2009;53:e22-e22.
FULL TEXT
Discordant Secular Trends in Elevated Blood Pressure and Obesity in Children and Adolescents in a Rapidly Developing Country
Chiolero et al.
Circulation 2009;119:558-565.
ABSTRACT
| FULL TEXT
Heart Disease and Stroke Statistics--2009 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee
WRITING GROUP MEMBERS et al.
Circulation 2009;119:e21-e181.
FULL TEXT
The Relationship Between Obesity and Atherosclerotic Progression and Prognosis Among Patients With Coronary Artery Bypass Grafts: The Effect of Aggressive Statin Therapy
Wee et al.
J Am Coll Cardiol 2008;52:620-625.
ABSTRACT
| FULL TEXT
Population-Based Prevention of Obesity: The Need for Comprehensive Promotion of Healthful Eating, Physical Activity, and Energy Balance: A Scientific Statement From American Heart Association Council on Epidemiology and Prevention, Interdisciplinary Committee for Prevention (Formerly the Expert Panel on Population and Prevention Science)
Kumanyika et al.
Circulation 2008;118:428-464.
ABSTRACT
| FULL TEXT
Weighing in on Weight Screening in the Dental Office: Practical Approaches
Hague and Touger-Decker
Journal of the American Dental Association 2008;139:934-938.
ABSTRACT
| FULL TEXT
Trends in Diabetes, High Cholesterol, and Hypertension in Chronic Kidney Disease Among U.S. Adults: 1988-1994 to 1999-2004
Fox and Muntner
Diabetes Care 2008;31:1337-1342.
ABSTRACT
| FULL TEXT
Beyond Established and Novel Risk Factors: Lifestyle Risk Factors for Cardiovascular Disease
Mozaffarian et al.
Circulation 2008;117:3031-3038.
FULL TEXT
Update on Obesity
Bessesen
J. Clin. Endocrinol. Metab. 2008;93:2027-2034.
ABSTRACT
| FULL TEXT
The Impact of Obesity on Cardiovascular Disease Risk Factors and Subclinical Vascular Disease: The Multi-Ethnic Study of Atherosclerosis
Burke et al.
Arch Intern Med 2008;168:928-935.
ABSTRACT
| FULL TEXT
Trends in overweight, obesity and blood pressure among Israeli working adults--implications for public health
Sheffer and Calderon-Margalit
Eur J Public Health 2008;18:121-125.
ABSTRACT
| FULL TEXT
All High-Risk Patients Should Not Be Screened With Computed Tomographic Angiography
Kramer
Circulation 2008;117:1333-1339.
FULL TEXT
Trends and Cardiovascular Mortality Effects of State-Level Blood Pressure and Uncontrolled Hypertension in the United States
Ezzati et al.
Circulation 2008;117:905-914.
ABSTRACT
| FULL TEXT
The Canary in the Coal Mine of Coronary Artery Disease
Olshansky and Persky
Arch Intern Med 2008;168:261-261.
FULL TEXT
Is the obesity epidemic exaggerated? Yes
Basham and Luik
BMJ 2008;336:244-244.
FULL TEXT
Heart Disease and Stroke Statistics--2008 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Writing Group Members et al.
Circulation 2008;117:e25-e146.
FULL TEXT
Adolescent Overweight and Future Adult Coronary Heart Disease
Bibbins-Domingo et al.
NEJM 2007;357:2371-2379.
ABSTRACT
| FULL TEXT
Obesity, mortality, and bariatric surgery death rates.
Livingston
JAMA 2007;298:2406-2408.
FULL TEXT
The Changing Relationship of Obesity and Disability, 1988-2004
Alley and Chang
JAMA 2007;298:2020-2027.
ABSTRACT
| FULL TEXT
Cause-Specific Excess Deaths Associated With Underweight, Overweight, and Obesity
Flegal et al.
JAMA 2007;298:2028-2037.
ABSTRACT
| FULL TEXT
Prevalence of Chronic Kidney Disease in the United States
Coresh et al.
JAMA 2007;298:2038-2047.
ABSTRACT
| FULL TEXT
Is Disability Obesity's Price of Longevity?
Gregg and Guralnik
JAMA 2007;298:2066-2067.
FULL TEXT
Reframing The Debate Over Health Care Reform: The Role Of System Performance And Affordability
Thorpe
Health Aff (Millwood) 2007;26:1560-1562.
ABSTRACT
| FULL TEXT
Differences In Disease Prevalence As A Source Of The U.S.-European Health Care Spending Gap
Thorpe et al.
Health Aff (Millwood) 2007;26:w678-w686.
ABSTRACT
| FULL TEXT
End-Stage Renal Disease in the United States: An Update from the United States Renal Data System
Foley and Collins
J. Am. Soc. Nephrol. 2007;18:2644-2648.
ABSTRACT
| FULL TEXT
Suicide: A Weighty Matter? Reply
Mukamal et al.
Arch Intern Med 2007;167:1908-1908.
FULL TEXT
Trends In The Health Of Older Americans, 1970 2005
Kramarow et al.
Health Aff (Millwood) 2007;26:1417-1425.
ABSTRACT
| FULL TEXT
Economics of Health and Mortality Special Feature: Nature and causes of trends in male diabetes prevalence, undiagnosed diabetes, and the socioeconomic status health gradient
Smith
Proc. Natl. Acad. Sci. USA 2007;104:13225-13231.
ABSTRACT
| FULL TEXT
Obesity, Inflammation, and Periodontal Disease
Pischon et al.
JDR 2007;86:400-409.
ABSTRACT
| FULL TEXT
Islet Cell Dysfunction in Progression to Diabetes Mellitus
Spellman
JAOA: Journal of the American Osteopathic Association 2007;107:S1-S5.
ABSTRACT
| FULL TEXT
African-American and Hispanic ethnicities, renal involvement and obesity predispose to hypertension in systemic lupus erythematosus: results from LUMINA, a multiethnic cohort (LUMINAXLV)
Chaiamnuay et al.
Ann Rheum Dis 2007;66:618-622.
ABSTRACT
| FULL TEXT
Optimal Treatment of Obesity-Related Hypertension: The Hypertension-Obesity-Sibutramine (HOS) Study
Scholze et al.
Circulation 2007;115:1991-1998.
ABSTRACT
| FULL TEXT
Nine-Year Changes in Cardiovascular Disease Risk Factors with Weight Maintenance in the Atherosclerosis Risk in Communities Cohort
Truesdale et al.
Am J Epidemiol 2007;165:890-900.
ABSTRACT
| FULL TEXT
Heterogeneity in the Prevalence of Risk Factors for Cardiovascular Disease and Type 2 Diabetes Mellitus in Obese Individuals: Effect of Differences in Insulin Sensitivity
McLaughlin et al.
Arch Intern Med 2007;167:642-648.
ABSTRACT
| FULL TEXT
Increasing Cardiovascular Disease Burden Due to Diabetes Mellitus: The Framingham Heart Study
Fox et al.
Circulation 2007;115:1544-1550.
ABSTRACT
| FULL TEXT
Consistently Stable or Decreased Body Mass Index in Young Adulthood and Longitudinal Changes in Metabolic Syndrome Components: The Coronary Artery Risk Development in Young Adults Study
Lloyd-Jones et al.
Circulation 2007;115:1004-1011.
ABSTRACT
| FULL TEXT
Heart Disease and Stroke Statistics--2007 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Rosamond et al.
Circulation 2007;115:e69-e171.
FULL TEXT
Effect of obesity on inpatient rehabilitation outcomes following total knee arthroplasty
Vincent et al.
Clin Rehabil 2007;21:182-190.
ABSTRACT
An Overview Of Cardiovascular Disease Burden In The United States
Mensah and Brown
Health Aff (Millwood) 2007;26:38-48.
ABSTRACT
| FULL TEXT
The Triple Threat for Chronic Disease: Obesity, Race, and Depression
Stecker et al.
Psychosomatics 2006;47:513-518.
ABSTRACT
| FULL TEXT
Baseline characteristics of the randomised cohort from the Look AHEAD (Action for Health in Diabetes) study
Bray
Diabetes and Vascular Disease Research 2006;3:202-215.
ABSTRACT
A controlled trial of a school-based environmental intervention to improve physical activity in Dutch children: JUMP-in, kids in motion
Jurg et al.
HEALTH PROMOT INT 2006;21:320-330.
ABSTRACT
| FULL TEXT
Socioeconomic Status and Trends in Disparities in 4 Major Risk Factors for Cardiovascular Disease Among US Adults, 1971-2002
Kanjilal et al.
Arch Intern Med 2006;166:2348-2355.
ABSTRACT
| FULL TEXT
The Year in Epidemiology, Health Services Research, and Outcomes Research
Krumholz and Masoudi
J Am Coll Cardiol 2006;48:1886-1895.
FULL TEXT
The Chronic Kidney Disease Epidemic: Stepping Back and Looking Forward
Kiberd
J. Am. Soc. Nephrol. 2006;17:2967-2973.
ABSTRACT
| FULL TEXT
Gender and the Burden of Disease Attributable to Obesity
Muennig et al.
AJPH 2006;96:1662-1668.
ABSTRACT
| FULL TEXT
The medical complications of obesity
Malnick and Knobler
QJM 2006;99:565-579.
FULL TEXT
The Rise In Spending Among Medicare Beneficiaries: The Role Of Chronic Disease Prevalence And Changes In Treatment Intensity
Thorpe and Howard
Health Aff (Millwood) 2006;25:w378-w388.
ABSTRACT
| FULL TEXT
Temporal Trends in Prevalence of Diabetes Mellitus in a Population-Based Cohort of Incident Myocardial Infarction and Impact of Diabetes on Survival
Gandhi et al.
Mayo Clin Proc. 2006;81:1034-1040.
ABSTRACT
| FULL TEXT
Preventing Cardiovascular Disease and Diabetes: A call to action from the American Diabetes Association and the American Heart Association
Eckel et al.
Diabetes Care 2006;29:1697-1699.
FULL TEXT
Preventing Cardiovascular Disease and Diabetes: A Call to Action From the American Diabetes Association and the American Heart Association
Eckel et al.
Circulation 2006;113:2943-2946.
FULL TEXT
Trends in the Incidence of Type 2 Diabetes Mellitus From the 1970s to the 1990s: The Framingham Heart Study
Fox et al.
Circulation 2006;113:2914-2918.
ABSTRACT
| FULL TEXT
Socioeconomic, psychosocial, behavioural, and psychological determinants of BMI among young women: differing patterns for underweight and overweight/obesity
Ali and Lindstrom
Eur J Public Health 2006;16:324-330.
ABSTRACT
| FULL TEXT
Impact of Body Mass Index on Cardiac Mortality in Patients With Known or Suspected Coronary Artery Disease Undergoing Myocardial Perfusion Single-Photon Emission Computed Tomography
Kang et al.
J Am Coll Cardiol 2006;47:1418-1426.
ABSTRACT
| FULL TEXT
Improvement in Stroke Mortality in Canada and the United States, 1990 to 2002
Yang et al.
Circulation 2006;113:1335-1343.
ABSTRACT
| FULL TEXT
Trend in the prevalence of the metabolic syndrome and its impact on cardiovascular disease incidence: the san antonio heart study.
Lorenzo et al.
Diabetes Care 2006;29:625-630.
ABSTRACT
| FULL TEXT
Impact of the Increasing Burden of Diabetes on Acute Myocardial Infarction in New York City: 1990-2000
Fang and Alderman
Diabetes 2006;55:768-773.
ABSTRACT
| FULL TEXT
Heart Disease and Stroke Statistics--2006 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Thom et al.
Circulation 2006;113:e85-e151.
FULL TEXT
Commentary: Obesity and mortality--light at the end but still a long tunnel
Caballero and Wang
Int J Epidemiol 2006;35:21-22.
FULL TEXT
Commentary: Prescient visions of public health from Cornaro to Breslow
Olshansky
Int J Epidemiol 2006;35:22-23.
FULL TEXT
Commentary: Obesity claims and controversies
Stevens et al.
Int J Epidemiol 2006;35:77-78.
FULL TEXT
Commentary: The epidemic of obesity--what's in a name?
Flegal
Int J Epidemiol 2006;35:72-74.
FULL TEXT
Recent Trends in Cardiovascular Complications Among Men and Women With and Without Diabetes
Booth et al.
Diabetes Care 2006;29:32-37.
ABSTRACT
| FULL TEXT
The Rise In Health Care Spending And What To Do About It
Thorpe
Health Aff (Millwood) 2005;24:1436-1445.
ABSTRACT
| FULL TEXT
Metabolic Syndrome and Cardiovascular Disease
Citrome
J Psychopharmacol 2005;19:84-93.
ABSTRACT
Trends in Bariatric Surgical Procedures
Santry et al.
JAMA 2005;294:1909-1917.
ABSTRACT
| FULL TEXT
All obese individuals are not created equal: insulin resistance is the major determinant of cardiovascular disease in overweight/obese individuals
Reaven
Diabetes and Vascular Disease Research 2005;2:105-112.
ABSTRACT
Underweight, Overweight, Obesity, and Excess Deaths
Willett et al.
JAMA 2005;294:551-551.
FULL TEXT
CDC Casts Obesity-Related Death Toll in New Light
Goldfarb
DOC News 2005;2:1-3.
FULL TEXT
Misdirection on the Road to Shangri-La
Olshansky et al.
Sci Aging Knowl Environ 2005;2005:pe15-pe15.
ABSTRACT
| FULL TEXT
Trends in Obesity-Related Death and Cardiovascular Risk
Journal Watch Cardiology 2005;2005:1-1.
FULL TEXT
Deaths associated with obesity may be declining in the United States
Mayor
BMJ 2005;330:921-921.
FULL TEXT
Excess Deaths Associated With Underweight, Overweight, and Obesity
Flegal et al.
JAMA 2005;293:1861-1867.
ABSTRACT
| FULL TEXT
Deaths Attributable to Obesity
Mark
JAMA 2005;293:1918-1919.
FULL TEXT
|
